Realcan Pharmaceutical Group Co.,Ltd.’s Net Profit Dropped 41% in First Quarter of 2022

Realcan Pharmaceutical Group Co.,Ltd. (瑞康医药集团股份有限公司) (002589.SZ) reported a net profit of 98.6 million yuan in the first quarter of 2022, down 41% year-on-year.

Meanwhile, the company posted 4.1 billion yuan in revenue, down 29% year-on-year.

At the end of the reporting period, it had 27.5 billion yuan in total assets and 17.9 billion yuan in total liabilities, with a liability-to-asset ratio of 65.2%.